Guerre P, Larroque C, Pineau T, Burgat V, Galtier P
Unité associée I.N.R.A. de Physiopathologie et Toxicologie expérimentales, E.N.V.T., Toulouse, France.
Life Sci. 1996;58(21):1883-9. doi: 10.1016/0024-3205(96)00172-5.
The administration of aflatoxin B1 (AFB1) in New Zealand rabbit for 5 days at a daily oral dose of 0.05 or 0.1 mg/kg decreased microsomal hepatic cytochrome P450 whereas a dose-dependent increase in the reduced microsomal 420 nm absorption occurred. The nature of such an absorption was then investigated. Either in vitro incubation of control microsomal proteins with AFB1 up to 800 microM and NADPH, or primary rabbit hepatocyte cultures exposure to AFB1 up to 30 microM for 24 to 72 h, failed to produce any 420 nm absorbing species, suggesting that the 420 nm absorption observed in vivo was due to an hemoprotein increase. Chemical reductions of microsomal proteins from AFB1-treated rabbits confirmed this hypothesis. Enzyme activity determinations revealed an increase in both microsomal heme oxygenase and NADPH-cytochrome c reductase activities in AFB1 treated rabbits, suggesting that the 420 nm absorption observed in vivo was related to a particular increase in heme oxygenase.
给新西兰兔每日口服剂量为0.05或0.1毫克/千克的黄曲霉毒素B1(AFB1),持续5天,可使肝微粒体细胞色素P450减少,而微粒体在420纳米处的还原吸收则呈剂量依赖性增加。随后对这种吸收的性质进行了研究。用高达800微摩尔的AFB1和NADPH对对照微粒体蛋白进行体外孵育,或将原代兔肝细胞培养物暴露于高达30微摩尔的AFB1中24至72小时,均未产生任何在420纳米处有吸收的物质,这表明体内观察到的420纳米吸收是由于血蛋白增加所致。对AFB1处理过的兔子的微粒体蛋白进行化学还原证实了这一假设。酶活性测定显示,AFB1处理过的兔子的微粒体血红素加氧酶和NADPH-细胞色素c还原酶活性均增加,这表明体内观察到的420纳米吸收与血红素加氧酶的特定增加有关。